A healthcare provider will give the injection, usually during surgery, chemotherapy, or a medical procedure.Metoclopramide oral is taken for only 4 to 12 weeks.Metoclopramide is usually taken 30 minutes before meals and at bedtime, or only with meals that usually cause heartburn. Pharmacokinetics and clinical pharmacology of selegiline. Practice guideline for the treatment of patients with Alzheimer’s disease and other dementias of late life. This could result in serotonin syndrome.Tetrabenazine: May enhance the adverse/toxic effect of Monoamine Oxidase Inhibitors.Tetrahydrozoline (Nasal): Monoamine Oxidase Inhibitors may enhance the hypertensive effect of Tetrahydrozoline (Nasal). Frankel JP, Kempster PA, Stibe CMH et al. Mahmood I, Marinac JS, Willsie S et al. AtoMOXetine: Monoamine Oxidase Inhibitors may enhance the neurotoxic (central) effect of AtoMOXetine. L-deprenyl in the treatment of mild dementia of the alzheimer type: preliminary results.

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021479s000_MedR_P4.pdf154. The Parkinson Study Group. 97-414), to June 30, 1994. Carrillo MC, Ivy GO, Milgram NW et al. Many drugs can affect metoclopramide, especially:tetracycline (Ala-Tet, Brodspec, Panmycin, Sumycin, Tetracap);atropine (Donnatal, and others), benztropine (Cogentin), dimenhydrinate (Dramamine), methscopolamine (Pamine), or scopolamine (Transderm-Scop);bladder or urinary medications such as darifenacin (Enablex), flavoxate (Urispas), oxybutynin (Ditropan, Oxytrol), tolterodine (Detrol), or solifenacin (Vesicare);bronchodilators such as ipratroprium (Atrovent) or tiotropium (Spiriva);irritable bowel medications such as dicyclomine (Bentyl), hyoscyamine (Anaspaz, Cystospaz, Levsin), or propantheline (Pro-Banthine);an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate); ormedicines to treat psychiatric disorders, such as chlorpromazine (Thorazine), clozapine (Clozaril, FazaClo), haloperidol (Haldol), olanzapine (Zyprexa, Symbyax), prochlorperazine (Compazine), risperidone (Risperdal), thiothixene (Navane), and others.This list is not complete and there are many other drugs that can interact with metoclopramide.
Selective acetylenic ’suicide’ and reversible inhibitors of monoamine oxidase types A and B. Drachman DA, Leber P. treatment of Alzheimer’s disease—searching or a breakthrough, settling for less. This could result in serotonin syndrome. Select one or more newsletters to continue. Follow the directions on your prescription label and read all medication guides.

Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline. (2006) ZELAPAR (selegiline hydrochloride) is available as: NDC 0187-0453-02, carton of 6 pouches (60 tablets). Closely monitor all antidepressant-treated patients for clinical worsening and for emergence of suicidal thoughts and behaviors.Selegiline transdermal patch is contraindicated in patients less than 12 years of age because of an increased risk of hypertensive crisis.• The possibility of a suicide attempt is inherent in major depression and may persist until remission occurs. 47.

Patients should be monitored closely and periodic skin examinations should be performed.• Psychosis: Orally disintegrating tablets: May cause new or worsening mental status and behavioral changes (may be severe) including hallucinations and psychotic-like behavior with initiation of therapy, after dose increases, or during the course of therapy. Selegiline Hydrochloride Pharmacokinetics Absorption Bioavailability. 97. Existing MAOI therapy can result in paradoxical effects of added reserpine (e.g., excitation, hypertension). This could result in serotonin syndrome.Diphenoxylate: May enhance the hypertensive effect of Monoamine Oxidase Inhibitors.Domperidone: Monoamine Oxidase Inhibitors may enhance the adverse/toxic effect of Domperidone. 27.
Csanda E, Tárczy M. Selegiline in the early and late phases of Parkinson’s disease.